TL Genomics Investors
TL Genomics is a developer of a prenatal diagnosis technology created to isolate fetal nucleated red blood cells in maternal blood.
Connections
Founded Date:
2015
Employee Number:
11-50
Investor Type:
Healthcare Company
Headquarters:
Koganei, Tokyo, Japan
Industry:
Deep Diagnostics